- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/08 - Heterocyclic compounds containing purine ring systems with oxygen, sulfur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Patent holdings for IPC class C07D 473/08
Total number of patents in this class: 107
10-year publication summary
|
6
|
11
|
9
|
8
|
6
|
4
|
6
|
9
|
3
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Agency for Science, Technology and Research | 3733 |
11 |
| Eli Lilly and Company | 4101 |
4 |
| Syngenta Participations AG | 1524 |
3 |
| Cubist Pharmaceuticals, Inc. | 10 |
3 |
| Fertis India Pvt. Ltd. | 71 |
3 |
| Adovate, LLC | 4 |
3 |
| Shanghai Degron Biomedical Technology Co., Ltd. | 5 |
3 |
| Genentech, Inc. | 4104 |
2 |
| Board of Regents, The University of Texas System | 6107 |
2 |
| Hydra Biosciences, Inc. | 30 |
2 |
| Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center | 175 |
2 |
| Mcmaster University | 833 |
2 |
| Oxford University Innovation Limited | 1663 |
2 |
| Pharmatrophix, Inc. | 25 |
2 |
| Theocorp Holding Company, LLC | 14 |
2 |
| Towa Pharmaceutical Co., Ltd. | 59 |
2 |
| The University of Tokyo | 4361 |
2 |
| West China Hospital, Sichuan University | 237 |
2 |
| Bioventures, LLC | 238 |
2 |
| Center for Intelligent Research in Crystal Engineering, S.L. | 22 |
2 |
| Other owners | 51 |